Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trialAlessandro Gronchi, Paolo G. Casali, Stefano Ferrari et al.|The Lancet Oncology|2017Cited by 493
Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: A phase I–II study from the Italian Sarcoma GroupAlessandro Gronchi, Paolo G. Casali, Antonino De Paoli et al.|European Journal of Cancer|2013Cited by 92
Gonadotropin Releasing Hormone Agonists Have an Anti-apoptotic Effect on Cumulus CellsPaola Scaruffi, Lucia Del Mastro, Sara Stigliani et al.|International Journal of Molecular Sciences|2019Cited by 20
Do guidelines influence breathlessness management in advanced lung diseases? A multinational survey of respiratory medicine and palliative care physiciansMałgorzata Krajnik, Sabina Panfilak, Jeremias Bazata et al.|BMC Pulmonary Medicine|2022Cited by 15
Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenibPaola Queirolo, Paolo A. Ascierto, Francesco Spagnolo et al.|Oncotarget|2016Cited by 12